REAL PROFESSIONAL EXPERIENCE · PHARMACEUTICAL SECTOR
How a pharmaceutical business unit increased annual sales by 50%
A business unit within a large pharmaceutical company faced stagnating sales despite leading its market. A strategy built around identifying opportunities, differentiation and continuous review coincided with higher annual sales and market share.

Experience predating the Luís Valente 360° brand · Organisation anonymised · Figures recalled from memory · No independent documentary audit
The challenge: leading without growing
The business unit held first place in its market, with a 25% market share and approximately €2 million in annual sales. Despite this leadership, growth over the previous 12 months was just 1.8%. The challenge was to restore commercial momentum without assuming market leadership meant demand was fully captured.
Diagnosis: expanding the addressable market
The strategic hypothesis was that some potential consumers had needs that had not yet been adequately identified. Existing market leadership informed the search for expansion opportunities, but did not itself guarantee future product preference.
Intervention: identification, differentiation and measurement
Screening initiatives aimed at consumers and communication highlighting product differentiators versus competitors were introduced. The strategy also involved sample-related activities; their distribution pathway and regulatory context have not been documented sufficiently for a public description. Management followed a cycle of problem identification, choice of measures, tracking, evaluation and reprioritisation.
Outcomes after 18 months
Comparable annual sales rose from approximately €2 million to €3 million, an increase of €1 million per year or 50%. Market share increased from 25% to 28%, a gain of 3 percentage points. The trailing 12-month year-on-year growth rate, measured at each endpoint, increased from 1.8% to 18%. The 50% change between annual sales figures over 18 months is different from the final 18% year-on-year growth rate.
Leadership contribution
The business unit manager identified the growth issue, guided the selection and implementation of actions, monitored indicators and reviewed priorities during the intervention. This was a professional experience predating the Luís Valente 360° brand, not a client engagement delivered by the consultancy.
Strategic takeaway
Market leadership does not mean all growth opportunities have been exhausted. Identifying unmet needs, differentiating the offering and reviewing decisions can help develop the market and strengthen performance.
How to interpret the outcomes of this case
- Context and responsibility
- Pharmaceutical business unit; commercial and strategic management responsibilities; an 18-month period.
- Reported outcomes
- Approximate annual sales: €2m → €3m; market share: 25% → 28%; final year-on-year growth: 18%.
- Source and verification
- Manager’s recollection, including approximate figures; no underlying historical records published.
- Interpretation limits
- The change cannot be attributed exclusively to the described actions; wider market factors were not isolated.
Practical relevance for SMEs
An SME can investigate unmet demand, sharpen its value proposition and monitor sales and conversion regularly.
This is a management takeaway, not a promise of identical results for other businesses.
Explore a related service